Getting Outcomes Measures to Sing in Harmony Not an Easy Task
by Joyce Frieden, News Editor, MedPage Today, April 28, 2017 WASHINGTON — Measuring outcomes for heart disease treatment in the general population won’t do much good if researchers can’t agree on a single definition of a particular disease or on which outcomes are worth measuring. That’s why a group of interested organizations is developing a common[…]
› READ THE ARTICLENEWS & ARTICLES
NEW PROJECT PUTS STANDARDIZED OUTCOMES MEASURES FOR DEPRESSION INTO REAL-WORLD USE, FROM REGISTRIES TO THE CLINIC
JUL 22, 2019
New Project Puts Standardized Outcomes Measures for Depression into Real-World Use, from Registries to the Clinic OM1 partners with AHRQ, ABFM, APA and others to implement BOSTON, July 17, 2019 —OM1, a leading health outcomes and technology company, today announced it is has been awarded the CAPSTONE – Outcome Measure Harmonization and Data Infrastructure for[…]
BHE & OM1 PARTNER TO DELIVER RHEUMATOLOGY REGISTRIES THROUGH IHD
MAY 14, 2019
Research-Grade, Analytic-Ready Rheumatology Data at Your Fingertips through the IHD Platform What would you do with rapid access to analytics and insights from hundreds of thousands of rheumatology patients? Bringing together the largest linked, longitudinal rheumatology condition registries with the industry-leading Instant Health Data (IHD) platform, OM1 and BHE join forces to deliver a powerful[…]
WHITE PAPERS
From Big Data to Measurable Outcomes: OBC
JUL 6, 2017
A heightened focus on value is driving efforts across health care to improve outcomes and reduce costs. For pharmaceutical companies, this focus translates into a shift away from traditional payment models to more outcomes-based, risk sharing agreements. In many ways, these agreements present the opportunity to better align interests across health care’s stakeholders. However, they[…]
Improving Performance under Bundled Care
NOV 5, 2016
The field of medicine is changing rapidly due to two major disruptions – the application of artificial intelligence, such as machine and deep learning and the shift from fee-for-service to value-based payment models. These innovations, which are occurring simultaneously, are fundamentally altering how data are used and how care is provided. To survive in this[…]
WEBINARS
From Big Data to Rapid Analytics for Rheumatology – Data Quality, Tools, and Usage
AUG 9, 2019
Wednesday, August 14, 2019 Being able to quickly and cost-effectively collect, analyze, and share real-world evidence on a treatment is critical to improving outcomes in rheumatology conditions. Fortunately, advances in data linkage and processing capabilities are enabling greater access to patient journeys via deep, linked clinical data. At the same time, new tools are empowering[…]
Aug 30 – Next Generation Registries: Big Data, Advanced Analytics, More Dynamic Evidence
AUG 14, 2018
August 30, 2018 – 2:00 – 3:00 pm ET Registries continue to be a critical part of the real-world evidence equation, but over time they have become too trialized, too burdensome, and too separated from real clinical practice. Emerging methodologies, data digitization, and cognitive technologies have set the path for drastic changes needed to address[…]